Global Cancer/Tumour Profiling Market: By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Others; By Biomarker Type; By Technology; By Application; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

7800
Present Value (M$)
2020
14000
Forecast Value (M$)
2026
10.2%
CAGR (%)

The global cancer/tumour profiling market attained a value of USD around 7.8 billion in 2020. The cancer/tumour profiling market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 10.2% to reach USD 14 billion by 2026.

Main companies

  • Illumina
  • Inc.
  • Qiagen N.V.
  • Neogenomic Laboratories
  • Inc.
  • Sysmex Corporation
  • HTG Molecular Diagnostics
  • Inc.
  • Helomics Corporation
  • Caris Life Sciences